Aventis S.A.

Prescription drugs, human vaccines, therapeutic proteins and 50% equity stake in Merial, an animal health joint venture with Merck & Co.

Activity:

Product / Technology type(s) covered:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
- Proteins

Therapeutic targets:

- Allergy
- Cardiovascular
- Diabetes
- Oncology
- Respiratory Medicine

Markets Covered

a. HeadQuarter: France

b. Continent(s) active: Europe , North America , Asia , Africa , Central/South America , Near/Middle East , Far East

c. Countries active:

Corporate data:

Number of Employees: 75000

Turnover:

Amount:	Year:	Currency:
17.7 billion	2001	Euro

Year founded: